{{Rsnum
|rsid=10228265
|Chromosome=7
|position=45869316
|Orientation=plus
|GMAF=0.3347
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 43.4 | 44.2 | 12.4
| HCB | 43.1 | 46.7 | 10.2
| JPT | 44.2 | 44.2 | 11.5
| YRI | 29.3 | 56.5 | 14.3
| ASW | 19.3 | 64.9 | 15.8
| CHB | 43.1 | 46.7 | 10.2
| CHD | 36.7 | 51.4 | 11.9
| GIH | 48.5 | 40.6 | 10.9
| LWK | 44.5 | 44.5 | 10.9
| MEX | 43.1 | 44.8 | 12.1
| MKK | 49.4 | 40.4 | 10.3
| TSI | 49.0 | 43.1 | 7.8
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19858071
|Title=Common Genetic Variation in IGF1, IGFBP1, and IGFBP3 and Ovarian Cancer Risk
|OA=1
}}

{{PMID Auto
|PMID=18596909
|Title=IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
|OA=1
}}

{{PMID Auto
|PMID=19551864
|Title=Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}